Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
88.19 USD | -0.50% |
|
-5.31% | -2.99% |
Summary: Colgate-Palmolive Company
- The company has a good ESG score relative to its sector, according to MSCI.
Highlights: Colgate-Palmolive Company
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The company returns high margins, thereby supporting business profitability.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses: Colgate-Palmolive Company
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- With a 2025 P/E ratio at 24.2 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- With an enterprise value anticipated at 3.87 times the sales for the current fiscal year, the company turns out to be overvalued.
- The company appears highly valued given the size of its balance sheet.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The group usually releases earnings worse than estimated.
Ratings Chart: Colgate-Palmolive Company
Source: Surperformance
ESG chart: Colgate-Palmolive Company
Source: MSCI
Fundamentals (Composite) | Global Valuation (Composite) | Financial estimates revisions (Composite) | Capi.($) | ||
---|---|---|---|---|---|
71.47B | |||||
370B | |||||
155B | |||||
62.46B | |||||
41.01B | |||||
27.28B | |||||
26.88B | |||||
18.84B | |||||
14.17B | |||||
9.65B | |||||
Average | 79.72B | ||||
Weighted average by Cap. |
Investor (Composite)
Trader (Composite)
ESG MSCI
A
Financials
Revenue growth
EPS growth
Capital Efficiency (Composite)
Net Margin
Financial Health (Composite)
Valuation
P/E
EV/Revenue
EV/EBITDA
PBR
Dividend Yield
Revisions
Revenue revisions (1 year)
Revenue revisions (4 months)
Revenue revisions (1 month)
EPS revisions (1 year)
EPS revisions (4 months)
Consensus
Analysts' buy/sell recommendations
Analysts' recommendations evolution (4 months)
Analysts' target price
Analysts' target price evolution (4 months)
Analysts' target price evolution (1 year)
Business Predictability
Surprise rates
Analysts' coverage
Analysts' recommendations divergence
Analysts' Target price divergence
Financial estimates divergence
ESG
Environment
Social
Governance
Controversy
Ethical controversies
Human rights controversies
Tax subsidies controversies
Sharia compliant
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- CL Stock
- Ratings Colgate-Palmolive Company
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition